&Partners’s Bio-Techne TECH Stock Holding History

&Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$701K	Sell	13,430 -1,903	-12%	-$114K	﹤0.01%	1501
2025 Q4	$902K	Buy	+15,333	New	+$932K	﹤0.01%	1280

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

&Partners's TECH Position: Q1 2026 in Review

&Partners reduced its Bio-Techne (TECH) stake by 12% in Q1 2026, selling an estimated $114K and leaving 13,430 shares worth $701K. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

&Partners first reported a position in TECH in Q4 2025 and has held it in 2 quarters since. The position peaked at $902K in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

&Partners held 13,430 shares of Bio-Techne worth $701K as of Q1 2026.
&Partners sold 1,903 Bio-Techne shares in Q1 2026, an estimated $114K.
Bio-Techne made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1501 holding.
&Partners first reported a position in Bio-Techne in Q4 2025 and has held it in 2 quarters since.
&Partners's Bio-Techne position peaked at $902K in Q4 2025.
582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.